OUTLOOK THERAPEUTICS, INC. Earnings Per Share (Diluted)
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Earnings Per Share (Diluted) of -$0.15 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-18
- OUTLOOK THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.15.
- OUTLOOK THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.05.
- OUTLOOK THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.38, a 152.78% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.55.
- OUTLOOK THERAPEUTICS, INC. earnings per share, diluted for fiscal 2025 was -$1.79.
- OUTLOOK THERAPEUTICS, INC. earnings per share, diluted for fiscal 2024 was -$4.06.
- OUTLOOK THERAPEUTICS, INC. earnings per share, diluted for fiscal 2023 was -$4.72.
- OUTLOOK THERAPEUTICS, INC. earnings per share, diluted for fiscal 2022 was -$0.31.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.15 10-Q · filed 2026-08-18 | -$0.51 10-Q · filed 2026-08-18 | ||||||
| 2026-03-31 | -$0.05 10-Q · filed 2026-05-15 | -$0.39 10-Q · filed 2026-05-15 | ||||||
| 2025-12-31 | -$0.38 10-Q · filed 2026-02-17 | |||||||
| 2025-09-30 | -$1.79 10-K · filed 2025-12-19 | |||||||
| 2025-06-30 | -$0.55 10-Q · filed 2026-08-18 | -$1.60 10-Q · filed 2026-08-18 | ||||||
| 2025-03-31 | -$1.50 10-Q · filed 2026-05-15 | -$1.05 10-Q · filed 2026-05-15 | ||||||
| 2024-12-31 | $0.72 10-Q · filed 2026-02-17 | |||||||
| 2024-09-30 | -$4.06 10-K · filed 2025-12-19 | |||||||
| 2024-06-30 | -$0.89 10-Q · filed 2025-08-14 | -$4.82 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | -$8.01 10-Q · filed 2025-05-15 | -$9.20 10-Q · filed 2025-05-15 | ||||||
| 2023-12-31 | -$0.86 10-Q · filed 2025-02-14 | -$0.04 10-Q · filed 2024-02-14 | ||||||
| 2023-09-30 | -$4.72 10-K · filed 2024-12-27 | -$0.24 10-K · filed 2023-12-22 | ||||||
| 2023-06-30 | -$1.61 10-Q · filed 2024-08-14 | -$0.08 10-Q · filed 2023-08-14 | -$3.73 10-Q · filed 2024-08-14 | -$0.19 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -$0.52 10-Q · filed 2024-05-15 | -$0.03 10-Q · filed 2023-05-15 | -$2.09 10-Q · filed 2024-05-15 | -$0.10 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | -$0.08 10-Q · filed 2024-02-14 | |||||||
| 2022-09-30 | -$0.31 10-K · filed 2023-12-22 | |||||||
| 2022-06-30 | -$0.08 10-Q · filed 2023-08-14 | -$0.25 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$0.09 10-Q · filed 2023-05-15 | -$0.17 10-Q · filed 2023-05-15 | ||||||
| 2021-12-31 | -$0.08 10-Q · filed 2023-02-14 | |||||||
| 2021-09-30 | -$0.35 10-K · filed 2022-12-29 | |||||||
| 2021-06-30 | -$0.07 10-Q · filed 2022-08-10 | -$0.27 10-Q · filed 2022-08-10 | ||||||
| 2021-03-31 | -$0.09 10-Q · filed 2022-05-13 | -$0.20 10-Q · filed 2022-05-13 | ||||||
| 2020-12-31 | -$0.12 10-Q · filed 2022-02-14 | |||||||
| 2020-09-30 | -$0.67 10-K · filed 2021-12-23 | |||||||
| 2020-06-30 | -$0.03 10-Q · filed 2021-08-13 | -$0.69 10-Q · filed 2021-08-13 | ||||||
| 2018-09-30 | -$1.22 10-K · filed 2018-12-18 | |||||||
| 2018-06-30 | -$0.26 10-Q · filed 2018-08-14 | -$0.59 derived: net income ÷ weighted average shares · filed 2019-08-14 | -$1.24 10-Q · filed 2018-08-14 | |||||
| 2018-03-31 | -$0.34 10-Q · filed 2018-05-15 | -$1.05 10-Q · filed 2018-05-15 | ||||||
| 2017-09-30 | -$1.80 10-K · filed 2018-12-18 | |||||||
| 2017-06-30 | -$0.22 10-Q · filed 2018-08-14 | -$1.53 10-Q · filed 2018-08-14 | ||||||
| 2017-03-31 | -$0.38 10-Q · filed 2018-05-15 | -$1.16 10-Q · filed 2018-05-15 | ||||||
| 2016-09-30 | -$3.67 10-K · filed 2017-12-29 | |||||||
| 2016-06-30 | -$1.60 10-Q · filed 2017-08-14 | -$3.43 10-Q · filed 2017-08-14 | ||||||
| 2016-03-31 | -$0.32 10-Q · filed 2017-05-15 | -$1.64 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |